Application of analytical methods for the structural characterization and purity assessment of N,N-dimethyltryptamine, a potent psychedelic agent isolated from Mimosa tenuiflora inner barks
Alain Gaujac, Sabrina Teixeira Martinez, Arão Araújo Gomes, Sandro José de Andrade, Ângelo Da Cunha Pinto, Jorge M. David, Sandro Navickiene, Jaílson B. de Andrade
Microchemical Journal April 5, 2012 DOI: 10.1016/j.microc.2012.03.033 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Method development and characterization Peer reviewed |
|---|---|
| Topics | Ayahuasca 5-MeO-DMT DMT |
| Keywords | Context archaeology Mass spectrometry Designer drug Hallucinogen Chromatography |
| Citations | 34 |
| Key points | DMT of >95% purity can be reliably extracted from Mimosa tenuiflora inner bark using a simple and fast method suitable for producing a chromatographic analytical standard. |
Abstract
N,N-dimethyltryptamine (DMT) is a psychoactive indole alkaloid present in beverages consumed in religious ceremonies and in neo-shamanic rituals all around the world. It is a substance banned in most countries, which makes its acquisition difficult. In Brazil, a beverage rich in DMT named ayahuasca is legally consumed in a religious context. On the other hand, DMT is a controlled drug, enforced by the Brazilian National Health Surveillance Agency (Agência Nacional de Vigilância Sanitária). The present study describes a simple and fast method to obtain N,N-dimethyltryptamine (DMT) from inner barks of Mimosa tenuiflora for the purpose of using it as a chromatographic analytical standard. Fourier transform infrared spectroscopy (FTIR), single and tandem stage mass spectrometry (MS), nuclear magnetic resonance spectroscopy (1H and 13C NMR) and melting point measurements were performed for the structural characterization of N,N-dimethyltryptamine. The results obtained were in agreement with previous literature reports. The purity of the compound (> 95%) was determined using ultraviolet (UV) absorption spectrometry with a tryptamine analytical standard.
Citations in the library
Cited by 17
- From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders Journal of Neurochemistry September 14, 2021
- Ayahuasca: Uses, Phytochemical and Biological Activities Natural Products and Bioprospecting May 27, 2019
- Bioinspired total synthesis and structural revision of yuremamine, an alkaloid from the entheogenic plant Mimosa tenuiflora Chemical Communications 2015
- Determination of N,N-dimethyltryptamine in beverages consumed in religious practices by headspace solid-phase microextraction followed by gas chromatography ion trap mass spectrometry Talanta February 1, 2013
- Conformational, spectroscopic and nonlinear optical properties of biologically active N,N-dimethyltryptamine molecule: a theoretical study. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy December 10, 2014
and 12 more in the library
Cites 20
- The Hallucinogen N,N -Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator Science February 13, 2009
- Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges. Pharmacology & Therapeutics May 1, 2004
- Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter. Journal of Neural Transmission September 12, 2009
- A critical review of reports of endogenous psychedelic N, N-dimethyltryptamines in humans: 1955-2010. Drug Testing and Analysis 2012
- Hallucinogenic Drugs and Plants in Psychotherapy and Shamanism Journal of Psychoactive Drugs December 1, 1998
and 15 more in the library